The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Philip Kam Tao Li

Department of Medicine and Therapeutics

Prince of Wales Hospital

The Chinese University of Hong Kong



Name/email consistency: high



  • Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, China. 1997 - 2010


  1. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial. Li, P.K., Cheng, Y.L., Leung, C.B., Szeto, C.C., Chow, K.M., Kwan, B.C., Ng, E.S., Fok, Q.W., Poon, Y.L., Yu, A.W. Clin. J. Am. Soc. Nephrol (2010) [Pubmed]
  2. Treatment of metabolic syndrome in peritoneal dialysis patients. Li, P.K., Kwan, B.C., Ko, G.T., Chow, K.M., Leung, C.B., Szeto, C.C. Perit. Dial. Int (2009) [Pubmed]
  3. Peritoneal dialysis patient selection: characteristics for success. Li, P.K., Chow, K.M. Advances. Chronic. Kidney. Disease (2009) [Pubmed]
  4. Increased utilization of peritoneal dialysis to cope with mounting demand for renal replacement therapy--perspectives from Asian countries. Li, P.K., Lui, S.L., Leung, C.B., Yu, A.W., Lee, E., Just, P.M., Abraham, G., Almazan-Gomez, L., Huang, C.C., Hooi, L.S., Kawaguchi, Y., Kuok, U.I., Tungsanga, K., Wang, T., Wong, A.K., Yu, X.Q., Lo, W.K. Perit. Dial. Int (2007) [Pubmed]
  5. Maximizing the success of peritoneal dialysis in high transporters. Li, P.K., Chow, K.M. Perit. Dial. Int (2007) [Pubmed]
  6. Continuous ambulatory peritoneal dialysis is better than automated peritoneal dialysis as first-line treatment in renal replacement therapy. Li, P.K., Chung, K.Y., Chow, K.M. Perit. Dial. Int (2007) [Pubmed]
  7. Therapeutic options for preservation of residual renal function in patients on peritoneal dialysis. Li, P.K., Cheng, Y.L. Perit. Dial. Int (2007) [Pubmed]
  8. Good patient and technique survival in elderly patients on continuous ambulatory peritoneal dialysis. Li, P.K., Law, M.C., Chow, K.M., Leung, C.B., Kwan, B.C., Chung, K.Y., Szeto, C.C. Perit. Dial. Int (2007) [Pubmed]
  9. Is angiotensin-converting-enzyme inhibition renoprotective in young patients with IgA nephropathy?. Li, P.K. Nature Clinical Practice. Nephrology (2007) [Pubmed]
  10. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. Li, P.K., Leung, C.B., Chow, K.M., Cheng, Y.L., Fung, S.K., Mak, S.K., Tang, A.W., Wong, T.Y., Yung, C.Y., Yung, J.C., Yu, A.W., Szeto, C.C. Am. J. Kidney Dis. (2006) [Pubmed]
  11. A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. Li, P.K., Weening, J.J., Dirks, J., Lui, S.L., Szeto, C.C., Tang, S., Atkins, R.C., Mitch, W.E., Chow, K.M., D'Amico, G., Freedman, B.I., Harris, D.C., Hooi, L.S., Jong, P.E., Kincaid-Smith, P., Lai, K.N., Lee, E., Li, F.K., Lin, S.Y., Lo, W.K., Mani, M.K., Mathew, T., Murakami, M., Qian, J.Q., Ramirez, S., Reiser, T., Tomino, Y., Tong, M.K., Tsang, W.K., Tungsanga, K., Wang, H., Wong, A.K., Wong, K.M., Yang, W.C., Zeeuw, D., Yu, A.W., Remuzzi, G. Kidney Int. Suppl. (2005) [Pubmed]
  12. The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients. Li, P.K., Chow, K.M. Perit. Dial. Int (2005) [Pubmed]
  13. Is there a survival advantage in Asian peritoneal dialysis patients?. Li, P.K., Chow, K.M., Szeto, C.C. Int. J. Artif. Organs (2003) [Pubmed]
  14. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Li, P.K., Chow, K.M., Wong, T.Y., Leung, C.B., Szeto, C.C. Ann. Intern. Med. (2003) [Pubmed]
  15. How to have--a successful peritoneal dialysis program. Li, P.K., Chow, K.M. Perit. Dial. Int (2003) [Pubmed]
  16. Prognostic indicators of IgA nephropathy in the Chinese--clinical and pathological perspectives. Li, P.K., Ho, K.K., Szeto, C.C., Yu, L., Lai, F.M. Nephrol. Dial. Transplant. (2002) [Pubmed]
  17. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study. Li, P.K., Law, M.C., Chow, K.M., Chan, W.K., Szeto, C.C., Cheng, Y.L., Wong, T.Y., Leung, C.B., Wang, A.Y., Lui, S.F., Yu, A.W. Am. J. Kidney Dis. (2002) [Pubmed]
  18. The cost barrier to peritoneal dialysis in the developing world--an Asian perspective. Li, P.K., Chow, K.M. Perit. Dial. Int (2001) [Pubmed]
  19. Adequacy targets of peritoneal dialysis in the Asian population. Li, P.K., Szeto, C.C. Perit. Dial. Int (2001) [Pubmed]
  20. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Li, P.K., Szeto, C.C., Law, M.C., Chau, K.F., Fung, K.S., Leung, C.B., Li, C.S., Lui, S.F., Tong, K.L., Tsang, W.K., Wong, K.M., Lai, K.N. Am. J. Kidney Dis. (1999) [Pubmed]
  21. Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy. Li, P.K., Tsang, K., Szeto, C.C., Wong, T.Y., To, K.F., Leung, C.B., Lui, S.F., Yu, S., Lai, F.M. Am. J. Kidney Dis. (1998) [Pubmed]
  22. Association of IgA nephropathy with T-cell receptor constant alpha chain gene polymorphism. Li, P.K., Poon, P., Phil, M., Poon, A.S., Szeto, C.C., Yu, A.W., Lai, K.N. Am. J. Kidney Dis. (1997) [Pubmed]
WikiGenes - Universities